公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2017 | Aptamer-Drug Conjugates of Active Metabolites of Nucleoside Analogs and Cytotoxic Agents Inhibit Pancreatic Tumor Cell Growth | Yoon S.; KAI-WEN HUANG ; Reebye V.; Spalding D.; Przytycka T.M.; Wang Y.; Swiderski P.; Li L.; Armstrong B.; Reccia I.; Zacharoulis D.; Dimas K.; Kusano T.; Shively J.; Habib N.; Rossi J.J. | Molecular Therapy - Nucleic Acids | 64 | 58 | |
2018 | Gene activation of CEBPA using saRNA: Preclinical studies of the first in human saRNA drug candidate for liver cancer | Reebye V.; KAI-WEN HUANG ; Lin V.; Jarvis S.; Cutilas P.; Dorman S.; Ciriello S.; Andrikakou P.; Voutila J.; Saetrom P.; Mintz P.J.; Reccia I.; Rossi J.J.; Huber H.; Habib R.; Kostomitsopoulos N.; Blakey D.C.; Habib N.A. | Oncogene | 63 | 54 | |
2017 | Impact of cavitron ultrasonic surgical aspirator (CUSA) and bipolar radiofrequency device (Habib-4X) based hepatectomy for hepatocellular carcinoma on tumour recurrence and diseasefree survival | KAI-WEN HUANG ; PO-HUANG LEE ; Kusano T.; Reccia I.; Jayant K.; Habib N. | Oncotarget | 15 | 10 | |
2020 | Liver Activation of Hepatocellular Nuclear Factor-4α by Small Activating RNA Rescues Dyslipidemia and Improves Metabolic Profile | KAI-WEN HUANG ; Reebye V.; Czysz K.; Ciriello S.; Dorman S.; Reccia I.; HONG-SHIEE LAI ; Peng L.; Kostomitsopoulos N.; Nicholls J.; Habib R.S.; Tomalia D.A.; S?trom P.; Wilkes E.; Cutillas P.; Rossi J.J.; Habib N.A. | Molecular Therapy - Nucleic Acids | 38 | 34 | |
2018 | A systematic review and meta-analysis comparing liver resection with the Rf-based device habib™-4X with the clamp-crush technique | Jayant K.; Sodergren M.H.; Reccia I.; Kusano T.; Zacharoulis D.; Spalding D.; Pai M.; Jiao L.R.; KAI-WEN HUANG | Cancers | 9 | 8 | |
2016 | Targeted Delivery of C/EBPα -saRNA by Pancreatic Ductal Adenocarcinoma-specific RNA Aptamers Inhibits Tumor Growth in Vivo | Yoon S.; KAI-WEN HUANG ; Reebye V.; Mintz P.; YU-WEN TIEN ; HONG-SHIEE LAI ; S?trom P.; Reccia I.; Swiderski P.; Armstrong B.; Jozwiak A.; Spalding D.; Jiao L.; Habib N.; Rossi J.J. | Molecular Therapy | 52 | 50 |